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Summary: The ability to control the architecture and strength of a bone tissue
engineering scaffold is critical to achieve a harmony between the scaffold and the
host tissue. Rapid prototyping (RP) technique is applied to tissue engineering to
satisfy this need and to create a scaffold directly from the scanned and digitized
image of the defect site. Design and construction of complex structures with
different shapes and sizes, at micro and macro scale, with fully interconnected pore
structure and appropriate mechanical properties are possible by using RP techniques.
In this study, RP was used for the production of poly(e-caprolactone) (PCL) scaffolds.
Scaffolds with four different architectures were produced by using different con-
figurations of the fibers (basic, basic-offset, crossed and crossed-offset) within the
architecture of the scaffold. The structure of the prepared scaffolds were examined by
scanning electron microscopy (SEM), porosity and its distribution were analyzed by
micro-computed tomography (m-CT), stiffness and modulus values were determined
by dynamic mechanical analysis (DMA). It was observed that the scaffolds had very
ordered structures with mean porosities about 60%, and having storage modulus
values about 1! 107 Pa. These structures were then seeded with rat bone marrow
origin mesenchymal stem cells (MSCs) in order to investigate the effect of scaffold
structure on the cell behavior; the proliferation and differentiation of the cells on
the scaffolds were studied. It was observed that cell proliferation was higher on offset
scaffolds (262000 vs 235000 for basic, 287000 vs 222000 for crossed structure) and
stainings for actin filaments of the cells reveal successful attachment and spreading
at the surfaces of the fibers. Alkaline phosphatase (ALP) activity results were higher
for the samples with lower cell proliferation, as expected. Highest MSC differentiation
was observed for crossed scaffolds indicating the influence of scaffold structure on
cellular activities.
Keywords: mesenchymal stem cell; poly(e-caprolactone); rapid prototyping; scaffold; tissue
engineering
Introduction
Bone tissue has the capacity of self-
reconstruction upon injury, however, when
the defect is large it usually remains
unrepaired[1] and require a filler, such as
cadaver bone, coral, hydroxyapatite or
similar mineral compounds. A tissue engi-
neered scaffold with tailored structural and
mechanical properties would be an ideal
filler. Conventional tissue engineering
scaffold production techniques such as
fiber bonding,[2] solvent casting/particulate
leaching,[3] membrane lamination,[4] melt
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molding[5] and gas foaming,[6] generally
lack the ability to produce structures with
predefined homogeneous structure. Instead,
they have such drawbacks as poor repro-
ducibility, irregularity of pore shape and
insufficient pore interconnectivity.
3D geometry of tissue engineering scaf-
folds is very important as it has a profound
effect on cell behavior in a successful tissue
engineered construct. In the study of Kenar
et al. effect of alignment on MSC prolifera-
tion and differentiation was investigated
on micropatterned poly(3-hydroxybutyrate-
co-3-hydroxyvalerate) (PHBV) and poly(L/
D,L-lactic acid) (P(L/DL)A) blend films.[7] It
was observed that alignment positively
influenced the differentiation of MSCs into
osteoblasts. In a similar study, the effect of
contact guidance on the construction of a
corneal stroma was investigated on kera-
tocyte seeded collagen films.[8] It was reported
that patterning induced the oriented secretion
of the extracellular matrix therefore
improving the properties of the construct.
It is known that the maintenance of
cellular activities and interconversions of
the connective-tissue cells (fibroblasts,
cartilage cells and bone cells) are highly
dependent on their shape and anchorage
which controls their gene expression.[9] The
arrangement within the architecture of a
scaffold defines the geometry of the adhe-
sion sites for the cells, thus determine their
adhesion, degree of spreading and cytoske-
leton orientation. Therefore, it was stated
that the cellular mobility, proliferation and
differentiation is dictated by the initial
attachment geometry and the strength of it.
The control of cellular activities is espe-
cially important in the case of stem cell
based tissue engineering therapies in which
controlled proliferation and differentiation
of stem cells is of utmost importance.
Rapid prototyping (RP) technique is
attractingmore andmore attention because
it is the ideal tool for creating a scaffold
directly from the scanned image and the
computer model of the defect site to pro-
vide a structurally and mechanically perfect
fit.[10] It is the process of creating 3D objects
through repetitive deposition of material
layers, a typical bottom-up approach, using
computer-controlled equipment, based on
the cross-sectional data obtained from slicing
a computer-aided design (CAD) model of
the object.[11] Besides having precise con-
trol over porosity, pore size, stiffness and
permeability; the RP scaffolds are usually
designed to have a fully interconnected
pore structure.[12] While creating scaffolds
with defined structure and architecture, RP
techniques also allow the investigation of
the effect of scaffold geometry on cell
behavior for further optimization of the
scaffold design.
Recent developments in solid free-form
fabrication techniques and improvement of
systems which can utilize polymers have
made it possible to design and manufacture
tailor-made tissue engineering scaffolds with
precise control. There are several approaches
for the production of RP scaffolds such as
selective laser sintering (SLS),[13] fused
deposition modeling (FDM),[14] 3D fiber
deposition[15] or 3D plotting.[16] Among the
available fabrication techniques, 3D plot-
ting is the most convenient method due to
its milder operation conditions, absence of
left over polymer powder within the scaf-
fold and the ability to produce scaffolds
without any binders. Thus, 3D plotting
appeared to be a very appropriate method
for producing bone tissue engineering
scaffolds.
Poly(e-caprolactone) (PCL) is a fully bio-
degradable, thermoplastic polyester with
potential applications for bone and carti-
lage repair and was successfully used as a
scaffold material in various forms.[17–18]
PCL has thermal stability in molten state
due to its such favorable properties as low
glass transition temperature ("60 8C), low
melting temperature (60 8C) and high
decomposition temperature (350 8C).[19]
PCL degrades very slowly, much slower
than PLGA or PHBV, due to its high
hydrophobicity and crystallinity[20] there-
fore it is suitable for use in long term load
bearing applications. A number of studies
are being carried out using PCL biocom-
posites and copolymers with both natural
and synthetic polymers.[19,21] PCL scaffolds
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have been created with a variety of RP
techniques including FDM[22], shape depo-
sition modeling[23], SLS[24], low-temperature
deposition[25] and multi-nozzle free-form
deposition.[26-27] It was observed in these
systems that the cells adhere and start
growing on the PCL scaffolds and the
applicability of the produced scaffolds were
demonstrated in vitro and in vivo. However,
the fabrication and characterization of PCL
scaffolds with varying architectures made
through 3D plotting has not been reported.
In this study, 3D plotting was used for
the production of poly(e-caprolactone)
(PCL) scaffolds for bone tissue engineering
purpose. SEM, m-CT and DMA analyses
were performed to characterize the pro-
duced structures in terms of structure,
porosity and mechanical properties. Scaf-
folds were produced with four different
architectures by changing the configuration
of the deposited fibers within the architec-
ture. This study intends to investigate the
effect of scaffold structure on the structural
and mechanical properties as well as the
effects on stem cell behavior.
Materials and Methods
Materials
Poly(e-caprolactone) (MW¼ 37000) was
purchased from Solvay Caprolactones under
the trade name CAPA 6404 (UK). Dulbec-
co’s Modified Eagle Medium (DMEM; high
glucose) was supplied byGibco (USA). Fetal
calf serum, trypsin/EDTA, penicillin/strep-
tomycin, Amphothericin B, glutaraldehyde,
formaldehyde, cacodylic acid (sodium salt),
dexamethasone, b-glycerophosphate diso-
dium salt, L-ascorbic acid were bought from
Sigma-Aldrich (Germany). NucleoCounter
reagents were supplied by Chemometec
(Denmark) and Alamar Blue cell prolif-
eration assay solution was from USBiolo-
gical. For the assessment of cell differentia-
tion, alkaline phosphatase kit (Randox,
USA) was used.
Scaffold Fabrication
Scaffolds were fabricated with a Bioplotter1
(Envisiontec GmbH, Germany). Briefly,
PCL was placed in a stainless steel syringe
and processed at 130 8C through a heated
cartridge unit. When the polymer melted,
a CO2 pressure was applied to the syringe
through a pressurized cap.Rectangular block
models (20! 20 mm of projected area) were
loaded on the Bioplotter CAD/CAM soft-
ware and scaffold was plotted layer-by-layer,
through the extrusion of the polymer as a
fiber, up to 10 layers. Scaffolds with different
architectures were produced by changing the
respective orientation of the deposited fibers.
PCL scaffolds were produced according to
four different standard architectures, namely:
basic (B), basic-offset (BO), crossed (C) and
crossed-offset (CO) structures. The B archi-
tecture is produced by the consecutive
deposition of 2D layers, in which layer N is
plotted orthogonally to layer N-1, and is
plotted in the same relative position of layer
N-2. The BO architecture is similar to B, but
layer N is plotted with in an offset distance
relative to layer N-2. The C architecture is
produced by the consecutive deposition of 2D
layers, in which layer N is plotted diagonally
to layer N-1, and is plotted in the same
relative position of layer N-4. The CO
architecture is similar to C, but layer N is
plotted with in an offset distance relative to
layer N-4. Final scaffolds were obtained using
a circular cutting die with 5 mm of diameter.
Scaffold Characterization
Structure and geometry of the scaffolds
were investigated by using a scanning elec-
tron microscope (Leica Cambridge S360,
Germany) after sputter coating with gold.
Porosity and porosity distribution were
assessed by using micro-computed tomo-
graphy (m-CT 20, SCANCO Medicals,
Switzerland). Scanner settings were 40 keV
and 248 mA. Entire scaffolds were scanned
in around 200 slices each of 7 mm thickness.
3 samples were analyzed for each scaffold
architecture. CTAnalyser andCTVolReali-
stic 3D Visualization (SkyScan, Belgium)
softwares were used for image processing in
CT reconstructions, and to create and
visualize the 3D representations.
Dynamic mechanical analysis (Perkin
Elmer DMA7e, USA) was used as a tool to
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relate material behavior with the molecular
structure, processing conditions and pro-
duct properties. An oscillating compressive
force was applied to the dry sample at 37 8C
and the resulting displacement of the sample
was measured, and from this, the stiffness of
the sample and the sample modulus were
calculated. The real (storage) modulus, E0,
and the imaginary (loss) modulus, E00,
components of the complex modulus, E
$
(where E
$ ¼E0þ iE00), were recorded
against frequency that varied between 0.1
and 70 Hz.
Cell Culture
Bone marrowmesenchymal stem cells were
isolated from 6 week old, male Sprague
Dawley rats. The rats were euthanized and
their femurs and tibia were excised, washed
with DMEM containing 1000 U/mL peni-
cillin and 1000 mg/mL streptomycin under
aseptic conditions. The marrow residing in
the midshaft was flushed out with DMEM
containing 20% fetal calf serum (FCS) and
100 U/mL penicillin and 100 mg/mL stre-
ptomycin, the cells were centrifuged at
500 g for 5 min, the resulting cell pellet was
resuspended and plated in T-75 flasks.
These primary cultures were incubated
for 2 days. The hematopoietic and other
unattached cells were removed from the
flasks by repeated washes with phosphate
buffer saline (PBS) (10 mM, pH 7.4) and
themedium of the flasks was renewed every
other day until confluency is reached. These
primary cultures were then stored frozen in
liquid nitrogen until use. Seeding density on
the scaffolds was 50000 cells per scaffold.
Incubation was performed at 37 8C and
5% CO2 in DMEM supplemented with
10% FCS, 10 mM b-glycerophosphate,
50 mg/mL L-ascorbic acid, 10 nM dexa-
methasone and penicillin/streptomycin/
amphotericin B. Viable cell number was
assessed with Alamar Blue assay (USBio-
logical). ALP activity was determined by
using Randox kit (USA). The absorbance
of p-nitrophenol formed from p-nitrophe-
nyl phosphate was determined at 405 nm
and calculation of enzyme amount was as
described by the manufacturer. Cell seeded
scaffolds were fixed with 4% p-formalde-
hyde in PBS (pH 7.4) for 15 min at the end
of 21 days of incubation, and treated with
triton X-100 (1%) for 5 min to permeabilize
the cell membranes. Samples were then
incubated at 37 8C for 1 h in bovine serum
albumin (BSA)-PBS (1%) solution prior to
staining with FITC-labeled phalloidin (for
actin filaments). The samples were studied
with a confocal microscope (Leica TCS
SPE, Germany).
Results and Discussion
Scaffold Production and Characterization
PCL scaffolds were prepared with four
different standard architectures designated
as basic (B), basic-offset (BO), crossed (C)
and crossed-offset (CO) structures (Figure 1).
Scaffold Porosity
The porosity and porosity distribution of
the scaffolds were investigated by using
m-CT. The porosity (%) values of the scaf-
folds indicate that the porosity of the
scaffolds are in the range 50–70% and are
somewhat dependent on the fiber orienta-
tion within the construct (Table 1). It was
also observed that the pores were comple-
tely interconnected throughout the whole
structure. The porosity profiles showed that
the porosity from top to bottom of the
scaffolds did not have a significant change
as expected from the precision of the pro-
duction method of the scaffolds by exact
placement of the polymer fibers during the
layer-by-layer deposition by the Bioplotter
(Figure 2). This is especially important
when most scaffolds produced by other
methods do not have complete connectivity
and the porosity decreases as one goes from
the surface towards the core leading to
insufficient population and oxygen/nutrient
concentrations in the core.
Mechanical Properties
The stiffness, the storage and loss modulus
values of the samples were calculated by
DMA analysis (Table 2). It was observed
that the change in fiber orientation in the
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scaffold from BO to B architecture results
in an increase in storage modulus from
3.48& 0.08! 106 Pa to 1.85& 0.19! 107 Pa;
while loss modulus increased from 2.64&
0.07! 105 Pa to 8.80& 0.01! 105 Pa. There-
fore, it can be stated that the mechanical
properties of a 3D plotted scaffold can
be, to some extend, tuned through the
adjustment of the fiber positioning within
the scaffold architecture, allowing for its
adaptation different tissue mechanical
requirements.
The storage moduli for cortical, demi-
neralized cortical and trabecular bone were
reported to be 8! 109, 2! 109 and 8!
105 Pa, respectively. The loss moduli for the
same samples were 2! 108, 7.5! 107 and
5.2! 104 Pa, respectively.[28-29] Therefore,
the PCL scaffolds exhibit higher stiffness as
compared to trabecular and lower stiffness
relatively to cortical bone in terms strorage
and loss moduli. Nevertheless, in order to
resist to the mechanical stresses in a cortical
bone implantation, these scaffolds should
be stiffer. However, it should be kept in
mind that the stiffness and strength in bone
are the result of the nano-scaled organiza-
tion of mineral and organic fractions. Since
the scaffolds cannot replicate such high
mechanical performance, it is expected that
the construct upon cell proliferation and
ECM secretion achieves comparable
mechanical properties to a living bone.
This analysis also showed that the PCL
scaffolds exhibit a viscoelastic behavior and
that although influential, the porosity is not
the sole determinant of the stiffness as
other factors such as number of junction
points between fibers and their relative
orientation can also influence mechanical
Figure 1.
SEM images of PCL scaffolds produced by the Bioplotter with different architectures. (a) B, (b) BO, (c) C, (d) CO
(!15). Inset pictures are the m-CT images of these scaffolds.
Table 1.
Mean porosity values of the scaffolds.
Scaffold Mean Porosity (%)
B 50.98& 3.16
BO 66.31& 4.35
C 65.00& 6.01
CO 56.80& 6.78
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properties. For example, structures BO and
C demonstrated almost similar porosities
(about 65%), but storage modulus values
were differed about 3.3 times (from 3.48!
106 to 1.15! 107 Pa). When the structures
are compared, it was observed that scaf-
folds without offset had higher compressive
stiffness due to juxtaposition of consecutive
filaments along the Z axis (Figure 3).
In Vitro Studies
PCL scaffolds were seeded with rat bone
marrow MSCs at a density of 5! 105 cells/
scaffold to assess suitability for use in bone
tissue engineering applications, prolifera-
tion andALP activity were tested after 7, 14
and 21 days of incubation.
Cell proliferation tests demonstrated
that both scaffolds with the offset resulted
in significantly higher cell proliferation
(Figures 4 and 5). This might be related
to the higher available fiber surface area on
the direct flow path of the media. During
cell seeding, the relative positioning of the
fibers will determine the type of flow path of
the media and, to a certain extend, the cell
seeding efficiency. When there is no offset,
cells have a clear open path which increases
the likelihood of cells passing the scaffold,
unless they move laterally during seeding.
On the contrary, when there is an offset
structure, fibers act as obstacles to the flow
providing a higher surface for cells to attach
to. This leads to improved initial adhesion
and subsequent higher cell numbers. For
almost all scaffolds (except C), cell numbers
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Figure 2.
Porosity distribution throughout PCL scaffolds.
Table 2.
Storage and loss modulus of 3D printed PCL scaffolds.
Storage Modulus (Pa) Loss Modulus (Pa)
B 1.85& 0.19! 107 8.80& 0.01! 105
BO 3.48& 0.08! 106 2.64& 0.07! 105
C 1.15& 0.09! 107 6.12& 0.05! 105
CO 9.69& 0.14! 106 5.32& 0.07! 105
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Figure 3.
Storage modulus vs. porosity for 3D printed PCL scaffolds.
Copyright ! 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.ms-journal.de
Macromol. Symp. 2008, 269, 92–99 97
were higher than that of tissue culture
polystyrene (TCPS) for all time points,
which was used as a reference, indicating
the successful cell-material interactions.
Also, the basic (B) system had higher cell
numbers which is interesting because C
appears to have more (30%) porosity.
In order to determine the cell behavior
and to qualitatively monitor cell growth,
cell seeded scaffolds were fixed and their
actin filaments were stained on day 21
(Figure 5). It was observed that the cells
attach and proliferate well on the fiber
surfaces of the scaffolds.
ALP activity per cell at specific time
points during incubation was measured in
order to investigate the degree of differ-
entiation of MSCs into osteoblastic cells
(Figure 6). As expected, there was no ALP
activity during the first week. In general,
0
50000
100000
150000
200000
250000
300000
350000
2520151050
Time (days)
Ce
ll 
N
um
be
r 
B
BO
C
CO
TCPS
Figure 4.
MSC proliferation on PCL scaffolds.
Figure 5.
FITC-labeled phalloidin staining on (a) B scaffold (x10), (b) C scaffold (!10) on day 21.
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Specific ALP Activity on PCL scaffolds.
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ALP results are in agreement with the cell
proliferation results; higher ALP activity
values were obtained for samples with
lower cell proliferation. Highest ALP
activity was measured on the 14th day for
all samples where cell proliferation rates
were lowest. Highest MSC differentiation
(highest ALP activity) was observed for
crossed scaffold (C) in agreement with the
higher proliferations with the basic types.
These results indicate that scaffold archi-
tecture determines cell response, in terms
of both seeding efficiency and proliferation.
Furthermore, cell differentiation, as mea-
sured by ALP activity, appears to be also
affected by scaffold structure, which indi-
cates that scaffold geometry can be opti-
mized for differentiation of MSC into the
osteoblast lineage.
Conclusion
One of themost critical aspects of a scaffold
intended for use as a bone substitute is the
ability to structurally fit to the defect site
and compensate for the inherent mechan-
ical stresses of the site. Application of rapid
prototyping techniques to the production of
bone tissue engineering scaffolds is the only
method available that can create such
predetermined form and structures. It was
shown in this study that the architecture of a
scaffold determines not only the physical
and mechanical properties, but also influ-
ences the cellular activities of the mesench-
ymal stem cells.
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